Beijing Chunlizhengda Medical Instruments (01858) released its performance for the first three quarters, with a net profit attributable to shareholders of 192 million yuan, a year-on-year increase of 213.21%.
Chunli Medical (01858) released its performance for the first three quarters of 2025, with the group achieving a revenue of 756 million yuan,...
Beijing Chunlizhengda Medical Instruments (01858) released its performance for the first three quarters of 2025. The group achieved operating income of 756 million yuan, an increase of 48.75% year-on-year; net profit attributable to shareholders of the listed company was 192 million yuan, an increase of 213.21% year-on-year. Basic earnings per share were 0.5 yuan.
Related Articles

US Stock Market Move | Navan (NAVN.US) is listed on the US stock market, and its opening stock price has fallen.

US Stock Market Move | Q3 net loss expands, Roblox (RBLX.US) falls more than 10%

US Stock Market Move | Moderna (MRNA.US) rose over 9% after news of negotiations for acquisition with at least one major pharmaceutical company.
US Stock Market Move | Navan (NAVN.US) is listed on the US stock market, and its opening stock price has fallen.

US Stock Market Move | Q3 net loss expands, Roblox (RBLX.US) falls more than 10%

US Stock Market Move | Moderna (MRNA.US) rose over 9% after news of negotiations for acquisition with at least one major pharmaceutical company.

RECOMMEND

First in History: NVIDIA’s Market Capitalization Tops $5 Trillion
30/10/2025

Congressional Budget Office Estimates Government Shutdown Has Cost the U.S. Economy $18 Billion
30/10/2025

Wall Street on China’s Internet Sector: Distinct Investment Opportunities in AI and Gaming; Caution on E‑commerce
30/10/2025


